Nucleic acids encoding PRO6308 polypeptides and related vectors and host cells
View Patent ↗The present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.
1. Isolated nucleic acid having at least 91% nucleic acid sequence identity to a nucleotide sequence that encodes a PRO6308 polypeptide having an amino acid sequence shown in FIG. 56 (SEQ ID NO:56), wherein said PRO6308 polypeptide is capable of stimulating endothelial cell tube formation in human umbilical vein endothelial cells (HUVEC cells).
2. Isolated nucleic acid having at least 91% nucleic acid sequence identity to a nucleotide sequence shown in FIG. 55 (SEQ ID NO:55), wherein said isolated nucleic acid encodes a PRO6308 polypeptide that is capable of stimulating endothelial cell tube formation in HUVEC cells.
3. Isolated nucleic acid having at least 91% nucleic acid sequence identity to the full-length coding sequence of the nucleotide sequence shown in FIG. 55 (SEQ ID NO:55), wherein said isolated nucleic acid encodes a PRO6308 polypeptide that is capable of stimulating endothelial cell tube formation in HUVEC cells.
4. Isolated nucleic acid having at least 91% nucleic acid sequence identity to the full-length coding sequence of the DNA deposited under ATCC accession number PTA-517, wherein said isolated nucleic acid encodes a PRO6308 polypeptide that is capable of stimulating endothelial cell tube formation in HUVEC cells.
5. A vector comprising the nucleic acid of claim 1 .
6. An isolated host cell comprising the vector of claim 5 .
7. The host cell of claim 6 , wherein said cell is a CHO cell.
8. The host cell of claim 6 , wherein said cell is an E. coli.
9. The host cell of claim 6 , wherein said cell is a yeast cell.
10. A process for producing a PRO6308 polypeptide comprising culturing the host cell of claim 6 under conditions suitable for expression of said PRO6308 polypeptide and recovering said PRO6308 polypeptide from the cell culture.
11. Isolated nucleic acid having at least 91% nucleic acid sequence identity to:
(a) a nucleotide sequence encoding the polypeptide shown in FIG. 56 (SEQ ID NO:56), lacking its associated signal peptide; or
(b) the complement of the isolated nucleic acid of (a),
wherein said isolated nucleic acid encodes a PRO6308 polypeptide that is capable of stimulating endothelial cell tube formation in HUVEC cells.
12. Isolated nucleic acid having a nucleotide sequence that encodes a PRO6308 polypeptide having the amino acid sequence shown in FIG. 56 (SEQ ID NO:56).
13. Isolated nucleic acid having the nucleotide sequence shown in FIG. 55 (SEQ ID NO:55).
14. Isolated nucleic acid having the full-length coding sequence of the nucleotide sequence shown in FIG. 55 (SEQ ID NO:55).
15. Isolated nucleic acid having the full-length coding sequence of the DNA deposited under ATCC accession number PTA-517.
16. A vector comprising the nucleic acid of claim 12 .
17. An isolated host cell comprising the vector of claim 16 .
18. The host cell of claim 17 , wherein said cell is a CHO cell.
19. The host cell of claim 17 , wherein said cell is an E. coli.
20. The host cell of claim 17 , wherein said cell is a yeast cell.
21. A process for producing a PRO6308 polypeptide comprising culturing the host cell of claim 17 under conditions suitable for expression of said PRO6308 polypeptide and recovering said PRO6308 polypeptide from the cell culture.